Similar articles for PMID: 26082022

Year	Number of Results
1993	1
1998	2
2001	3
2003	3
2004	9
2005	3
2006	7
2007	8
2008	8
2009	5
2010	5
2011	7
2012	3
2013	6
2014	5
2015	9
2016	6
2017	2
2018	3
2019	1
2020	5
2021	2
2022	2

1

Therapeutic effect of Active Hexose-Correlated Compound (AHCC) combined with CpG-ODN (oligodeoxynucleotide) in B16 melanoma murine model.

Ignacio RM, Kim CS, Kim YD, Lee HM, Qi XF, Kim SK. Ignacio RM, et al. Cytokine. 2015 Dec;76(2):131-137. doi: 10.1016/j.cyto.2015.06.002. Epub 2015 Jun 13. Cytokine. 2015. PMID: 26082022

2

Cancer immunotherapeutic effects of novel CpG ODN in murine tumor model.

Cho HC, Kim BH, Kim K, Park JY, Chang JH, Kim SK. Cho HC, et al. Int Immunopharmacol. 2008 Oct;8(10):1401-7. doi: 10.1016/j.intimp.2008.05.010. Epub 2008 Jun 18. Int Immunopharmacol. 2008. PMID: 18687302

3

Ameliorating effect of CpG-ODN (oligodeoxynucleotide) against radiation-induced lung injury in mice.

Park K, Dhupal M, Kim CS, Jung SH, Choi D, Qi XF, Kim SK, Lee JY. Park K, et al. Radiat Environ Biophys. 2020 Nov;59(4):733-741. doi: 10.1007/s00411-020-00871-w. Epub 2020 Sep 10. Radiat Environ Biophys. 2020. PMID: 32914274

4

Active hexose correlated compound enhances tumor surveillance through regulating both innate and adaptive immune responses.

Gao Y, Zhang D, Sun B, Fujii H, Kosuna K, Yin Z. Gao Y, et al. Cancer Immunol Immunother. 2006 Oct;55(10):1258-66. doi: 10.1007/s00262-005-0111-9. Epub 2005 Dec 16. Cancer Immunol Immunother. 2006. PMID: 16362410

5

CpG immunostimulatory oligodeoxynucleotide 1826 enhances antitumor effect of interleukin 12 gene-modified tumor vaccine in a melanoma model in mice.

Switaj T, Jalili A, Jakubowska AB, Drela N, Stoksik M, Nowis D, Basak G, Golab J, Wysocki PJ, Mackiewicz A, Sasor A, Socha K, Jakóbisiak M, Lasek W. Switaj T, et al. Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4165-75. doi: 10.1158/1078-0432.CCR-04-0022. Clin Cancer Res. 2004. PMID: 15217954

6

Synergistic antitumor effects of CpG oligodeoxynucleotide and STAT3 inhibitory agent JSI-124 in a mouse melanoma tumor model.

Molavi O, Ma Z, Hamdy S, Lai R, Lavasanifar A, Samuel J. Molavi O, et al. Immunol Cell Biol. 2008 Aug-Sep;86(6):506-14. doi: 10.1038/icb.2008.27. Epub 2008 Apr 8. Immunol Cell Biol. 2008. PMID: 18392040

7

The Application of Cytidyl Guanosyl Oligodeoxynucleotide Can Affect the Antitumor Immune Response Induced by a Combined Protocol of Cryoablation and Dendritic Cells in Lewis Lung Cancer Model.

Zhang M, Yin T, Lu Y, Feng H. Zhang M, et al. Med Sci Monit. 2016 Apr 19;22:1309-17. doi: 10.12659/msm.898194. Med Sci Monit. 2016. PMID: 27092689 Free PMC article.

8

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

de Jong S, Chikh G, Sekirov L, Raney S, Semple S, Klimuk S, Yuan N, Hope M, Cullis P, Tam Y. de Jong S, et al. Cancer Immunol Immunother. 2007 Aug;56(8):1251-64. doi: 10.1007/s00262-006-0276-x. Epub 2007 Jan 23. Cancer Immunol Immunother. 2007. PMID: 17242927

9

Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases.

Sfondrini L, Sommariva M, Tortoreto M, Meini A, Piconese S, Calvaruso M, Van Rooijen N, Bonecchi R, Zaffaroni N, Colombo MP, Tagliabue E, Balsari A. Sfondrini L, et al. Int J Cancer. 2013 Jul 15;133(2):383-93. doi: 10.1002/ijc.28028. Epub 2013 Feb 12. Int J Cancer. 2013. PMID: 23319306 Free article.

10

A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide.

Jia H, Guo J, Wang P, Sun K, Chen J, Ren W, Wei T, Yang Y, Li J, Liu X, Li R, Zhong J, Wang M, Tian Z, Feng Z, Zhao T. Jia H, et al. Int Immunopharmacol. 2020 Jun;83:106397. doi: 10.1016/j.intimp.2020.106397. Epub 2020 Mar 25. Int Immunopharmacol. 2020. PMID: 32220805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed